Literature DB >> 11142053

Technology assessment and the sociopolitics of health technologies.

P Lehoux1, S Blume.   

Abstract

In a growing number of countries, health technology assessment (HTA) has come to be seen as a vital component in policy making. Even though the assessment of the social, political, and ethical aspects of health technology is listed as one of its main objectives, in practice, the integration of such dimensions into HTA remains limited. Recent social scientific research on the inherently political nature of technology strongly supports such a comprehensive approach. The growing claims by and on behalf of consumer groups also suggest that HTA should be informed by a broader set of perspectives. Using the example of the cochlear implant in children, this essay compares the professed objectives of HTA with typical practice and explores possible explanations for the discrepancies observed. A second example, home telemonitoring for elderly persons, demonstrates how the types of evidence considered by HTA and the process through which assessments are produced may be reconsidered. We argue for the formal integration of the sociopolitical dimensions of health care technologies into assessments. The ability of HTA to more fully address important issues from a public policy point of view will increase by making explicit the sociopolitical nature of health care technologies.

Entities:  

Mesh:

Year:  2000        PMID: 11142053     DOI: 10.1215/03616878-25-6-1083

Source DB:  PubMed          Journal:  J Health Polit Policy Law        ISSN: 0361-6878            Impact factor:   2.265


  34 in total

1.  Understanding the normalization of telemedicine services through qualitative evaluation.

Authors:  Carl May; Robert Harrison; Tracy Finch; Anne MacFarlane; Frances Mair; Paul Wallace
Journal:  J Am Med Inform Assoc       Date:  2003-08-04       Impact factor: 4.497

Review 2.  Ethical challenges with welfare technology: a review of the literature.

Authors:  Bjørn Hofmann
Journal:  Sci Eng Ethics       Date:  2012-01-05       Impact factor: 3.525

3.  [Expensive drugs and intergenerational justice].

Authors:  David Hughes
Journal:  Can J Public Health       Date:  2010 May-Jun

Review 4.  The challenge of developing evidence-based genetics health care in practice.

Authors:  Brenda J Wilson
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

5.  The emergence of clinical practice guidelines.

Authors:  George Weisz; Alberto Cambrosio; Peter Keating; Loes Knaapen; Thomas Schlich; Virginie J Tournay
Journal:  Milbank Q       Date:  2007-12       Impact factor: 4.911

6.  Health technology assessment (HTA): ethical aspects.

Authors:  Dario Sacchini; Andrea Virdis; Pietro Refolo; Maddalena Pennacchini; Ignacio Carrasco de Paula
Journal:  Med Health Care Philos       Date:  2009-06-09

7.  Ethical, legal, and social issues in health technology assessment for prenatal/preconceptional and newborn screening: a workshop report.

Authors:  B K Potter; D Avard; V Entwistle; C Kennedy; P Chakraborty; M McGuire; B J Wilson
Journal:  Public Health Genomics       Date:  2008-09-03       Impact factor: 2.000

8.  Public attitudes towards genomic risk profiling as a component of routine population screening.

Authors:  S G Nicholls; B J Wilson; S M Craigie; H Etchegary; D Castle; J C Carroll; B K Potter; L Lemyre; J Little
Journal:  Genome       Date:  2013-08-31       Impact factor: 2.166

9.  Our perception of "Women's positive perception of transvaginal NOTES surgery": Let the voices be heard, not just counted.

Authors:  Francisco César Becerra Garcia; Karina Elizabeth Romo-Medrano Mora
Journal:  Surg Endosc       Date:  2010-05       Impact factor: 4.584

10.  Questioning context: a set of interdisciplinary questions for investigating contextual factors affecting health decision making.

Authors:  Andrea Charise; Holly Witteman; Sarah Whyte; Erica J Sutton; Jacqueline L Bender; Michael Massimi; Lindsay Stephens; Joshua Evans; Carmen Logie; Raza M Mirza; Marie Elf
Journal:  Health Expect       Date:  2010-10-28       Impact factor: 3.377

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.